Human Pulse: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Human Pulse
Largest movements
- Cash -€27,769
down €27,769 (-64.0%), from €43,423 to €15,654
mainly Net result for the year (-€27,885) and Receivables within one year (-€5,343)
- Receivables within one year +€5,343
new in 2025: €5,343
of which Trade receivables: +€5,292
- Deferred charges and accrued income -€905
down €905 (-100.0%), from €905 to €0
- Profit (loss) carried forward -€27,885
down €27,885 (-94.3%), from €29,574 to €1,689
- Other debts +€5,537
up €5,537 (+3124.9%), from €177 to €5,715
- Gross operating margin -€66,725
down €66,725, from €39,801 to -€26,924
- Taxes -€7,806
down €7,806 (-100.0%), from €7,806 to €0
- Depreciation -€1,441
down €1,441 (-100.0%), from €1,441 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,327 | €21,382 | -€22,946 | -51.8% |
| Current assets | 29/58 | €44,327 | €21,382 | -€22,946 | -51.8% |
| Stocks and contracts in progress | 3 | - | €385 | +€385 | |
| Stocks | 30/36 | - | €385 | +€385 | |
| Amounts receivable within one year | 40/41 | - | €5,343 | +€5,343 | |
| Trade receivables | 40 | - | €5,292 | +€5,292 | |
| Other amounts receivable | 41 | - | €51 | +€51 | |
| Cash at bank and in hand | 54/58 | €43,423 | €15,654 | -€27,769 | -64.0% |
| Deferred charges and accrued income | 490/1 | €905 | €0 | -€905 | -100.0% |
| Total equity and liabilities | 10/49 | €44,327 | €21,382 | -€22,946 | -51.8% |
| Equity | 10/15 | €32,574 | €4,689 | -€27,885 | -85.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €29,574 | €1,689 | -€27,885 | -94.3% |
| Amounts payable | 17/49 | €11,753 | €16,692 | +€4,939 | +42.0% |
| Amounts payable within one year | 42/48 | €11,753 | €16,484 | +€4,731 | +40.3% |
| Trade debts | 44 | €1,459 | €1,068 | -€390 | -26.8% |
| Suppliers | 440/4 | €1,459 | €1,068 | -€390 | -26.8% |
| Taxes, remuneration and social security | 45 | €10,117 | €9,701 | -€416 | -4.1% |
| Taxes | 450/3 | €10,117 | €9,701 | -€416 | -4.1% |
| Other amounts payable | 47/48 | €177 | €5,715 | +€5,537 | +3124.9% |
| Accrued charges and deferred income | 492/3 | - | €209 | +€209 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,441 | €0 | -€1,441 | -100.0% |
| Other operating charges | 640/8 | €942 | €884 | -€58 | -6.1% |
| Gross operating margin | 9900 | €39,801 | -€26,924 | -€66,725 | |
| Operating profit (loss) | 9901 | €37,418 | -€27,808 | -€65,227 | |
| Financial income | 75/76B | - | €179 | +€179 | |
| Recurring financial income | 75 | - | €179 | +€179 | |
| Financial charges | 65/66B | €38 | €255 | +€217 | +572.8% |
| Recurring financial charges | 65 | €38 | €255 | +€217 | +572.8% |
| Profit (loss) for the period before taxes | 9903 | €37,380 | -€27,885 | -€65,265 | |
| Income taxes | 67/77 | €7,806 | €0 | -€7,806 | -100.0% |
| Profit (loss) for the period | 9904 | €29,574 | -€27,885 | -€57,460 | |
| Profit (loss) for the period to be appropriated | 9905 | €29,574 | -€27,885 | -€57,460 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.